UK Drug Pricing & IP Targeted As US Gears Up For Post-Brexit Trade Deal Talks
The US has published its final negotiating objectives for a post-Brexit trade deal with the UK, which include pushing for stronger IP protections and changes to UK processes for patient access to new drugs.
You may also be interested in...
The Scottish National Party has put the NHS, EU membership and Scottish independence at the heart of its campaign as the UK prepares to vote in the 12 December general election.
Brexit and the NHS are likely to be key issues as political parties in the UK prepare to campaign ahead of the general election in December.
The National Institute for Health and Care Excellence does not agree with assertions by the US pharmaceutical industry that its HTA process are “rigid” and “fail to recognize the full value of innovative medicines.”